CUFinder

Shobhana K. Menon

About Shobhana K. Menon

Shobhana K. Menon, With an exceptional h-index of 34 and a recent h-index of 21 (since 2020), a distinguished researcher at Gujarat University, specializes in the field of Supramolecules, nanomaterials, forensic science.

His recent articles reflect a diverse array of research interests and contributions to the field:

Combination therapy is not associated with improved rates of clinical or endoscopic remission in patients with inflammatory bowel disease treated with ustekinumab or …

P667 USTEkinumAb Double intravenous loading induction therapY at week 0, 4 in patients with Crohn’s Disease–results from STEADY study

P753 Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes …

P147 Trends in choice of first line biologic therapy for patients with Inflammatory Bowel Disease. An observational cohort study

Microcarrier-Based Culture of Human Pluripotent Stem-Cell-Derived Retinal Pigmented Epithelium. Bioengineering 2022, 9, 297

P382 Novel Image Enhanced Endoscopy (IEE) technologies for surveillance of colonic Inflammatory Bowel Disease: A pilot study evaluating Texture and Colour Enhancement Imaging …

A portable microfluidic paper-based analytical device for blood detection and typing assay

Rationale, study design and methodology of the LANDMARC trial: a 3‐year, pan‐India, prospective, longitudinal study to assess management and real‐world outcomes of diabetes …

Shobhana K. Menon Information

University

Position

Retired Professor of Chemistry

Citations(all)

3611

Citations(since 2020)

1365

Cited By

3186

hIndex(all)

34

hIndex(since 2020)

21

i10Index(all)

97

i10Index(since 2020)

55

Email

University Profile Page

Google Scholar

Shobhana K. Menon Skills & Research Interests

Supramolecules

nanomaterials

forensic science

Top articles of Shobhana K. Menon

Combination therapy is not associated with improved rates of clinical or endoscopic remission in patients with inflammatory bowel disease treated with ustekinumab or …

Annals of Gastroenterology

2023/7

P667 USTEkinumAb Double intravenous loading induction therapY at week 0, 4 in patients with Crohn’s Disease–results from STEADY study

Journal of Crohn's and Colitis

2023/2/1

K Venugopal
K Venugopal

H-Index: 5

P753 Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes …

Journal of Crohn's and Colitis

2023/2/1

A Srinivasan
A Srinivasan

H-Index: 19

P147 Trends in choice of first line biologic therapy for patients with Inflammatory Bowel Disease. An observational cohort study

Journal of Crohn's and Colitis

2023/2/1

K Venugopal
K Venugopal

H-Index: 5

Microcarrier-Based Culture of Human Pluripotent Stem-Cell-Derived Retinal Pigmented Epithelium. Bioengineering 2022, 9, 297

Bioengineering

2022/7/4

P382 Novel Image Enhanced Endoscopy (IEE) technologies for surveillance of colonic Inflammatory Bowel Disease: A pilot study evaluating Texture and Colour Enhancement Imaging …

Journal of Crohn's and Colitis

2022/1/1

K Venugopal
K Venugopal

H-Index: 5

A portable microfluidic paper-based analytical device for blood detection and typing assay

Australian Journal of Forensic Sciences

2021/7/4

Rationale, study design and methodology of the LANDMARC trial: a 3‐year, pan‐India, prospective, longitudinal study to assess management and real‐world outcomes of diabetes …

Diabetic Medicine

2020/5

Investigation of pesticide residues in water, sediments and fish samples from Tapi River, India as a case study and its forensic significance

Environmental forensics

2020/1/2

The ubiquitylome of developing cortical neurons. microPublication Biology

2020

See List of Professors in Shobhana K. Menon University(Gujarat University)